Home
|
About Us
|
Products
|
Industry Links
|
Email Us
|
Contact Us
Oncology
In-Vitro Fertilization
Immunosuppression
PRODUCT NEWS
Revlimid (lenalidomide)
- granted an accelerated FDA approval under 21 CFR 314 Subpart H
Herceptin (Trastuzumab)
- New indications approved
Velcade (Bortezomib)
- New indications approved
Taxol (Paclitaxel)
- New indications approved
Home
|
About Us
|
Products
|
Industry Links
|
Email Us
|
Contact Us
Oncology
In-Vitro Fertilization
Immunosuppression
